Suscripción a Biblioteca: Guest
International Journal of Medicinal Mushrooms

Publicado 12 números por año

ISSN Imprimir: 1521-9437

ISSN En Línea: 1940-4344

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.2 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.4 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00066 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.34 SJR: 0.274 SNIP: 0.41 CiteScore™:: 2.8 H-Index: 37

Indexed in

Emerging Antiviral Drugs from Medicinal Mushrooms

Volumen 8, Edición 2, 2006, pp. 101-114
DOI: 10.1615/IntJMedMushr.v8.i2.20
Get accessGet access

SINOPSIS

Medicinal mushroom antivirals are a diverse group of chemical structures ranging from relatively low molecular weight compounds to high molecular weight carbohydrates and proteins. There is a paucity of information on the manner in which these antivirals interfere with viral replication. Mushroom-derived triterpenes and ubiquitin-associated peptides are examples of novel structures with potentially unique mechanisms of antiviral activity. Studies on these mechanisms will lead to the identification of targets for future drug development. Mushroom antivirals not previously reviewed are examined with these considerations in mind. Also reported here are original observations on the characterization and antiviral properties of a novel antiviral protein, RC 28, isolated from the mushroom Rozites caperatus. Elucidation of the antiviral mechanisms of mushroom antiviral drags are certain to advance the knowledge of viral replication and enhance the contribution of mushroom antivirals for the treatment of viral disease.

CITADO POR
  1. Gu Chang-Qing, Li Jun-Wen, Chao Fuhuan, Jin Min, Wang Xin-Wei, Shen Zhi-Qiang, Isolation, identification and function of a novel anti-HSV-1 protein from Grifola frondosa, Antiviral Research, 75, 3, 2007. Crossref

  2. Díaz-Godínez Gerardo, Fungal bioactive compounds, in Biotechnology of Bioactive Compounds, 2015. Crossref

  3. Rajesh K, Dhanasekaran Dharumadurai, Ganoderma: A bioresource of antimicrobials, in Antimicrobials, 2015. Crossref

  4. Zjawiony Jordan, Antimicrobial and Antiviral Metabolites from Polypore Fungi, in Novel Therapeutic Agents from Plants, 2009. Crossref

  5. Badalyan Susanna, Medicinal Aspects of Edible Ectomycorrhizal Mushrooms, in Edible Ectomycorrhizal Mushrooms, 34, 2012. Crossref

  6. Karwa Alka, Varma Ajit, Rai Mahendra, Edible Ectomycorrhizal Fungi: Cultivation, Conservation and Challenges, in Diversity and Biotechnology of Ectomycorrhizae, 25, 2011. Crossref

  7. Pérez-Moreno Jesús, Martínez-Reyes Magdalena, Edible Ectomycorrhizal Mushrooms: Biofactories for Sustainable Development, in Biosystems Engineering: Biofactories for Food Production in the Century XXI, 2014. Crossref

  8. Gholami-Shabani Mohammadhassan, Shams-Ghahfarokhi Masoomeh, Razzaghi-Abyaneh Mehdi, Natural Product Synthesis by Fungi: Recent Trends and Future Prospects, in Recent Advancement in White Biotechnology Through Fungi, 2019. Crossref

  9. Oke M. A., Afolabi F. J., Oyeleke O. O., Kilani T. A., Adeosun A. R., Olanbiwoninu A. A., Adebayo E. A., Ganoderma lucidum: Unutilized natural medicine and promising future solution to emerging diseases in Africa, Frontiers in Pharmacology, 13, 2022. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain